Human S100A12 is significantly overexpressed in the inflammatory compartment, and elevated serum levels of S100A12 are observed in patients with various inflammatory, neurodegenerative, metabolic, and neoplastic diseases (58, 59). This evidence concerns the gene S100A12 and neoplasm.